Mangoceuticals (MGRX) Accounts Payables (2022 - 2026)

Mangoceuticals has disclosed Accounts Payables across 5 years of filings, most recently posting $889733.0 for Q2 2026.

• In Q2 2026, Accounts Payables rose 15.85% year-over-year to $889733.0; the TTM figure through Jun 2026 stood at $889733.0 (up 15.85% YoY), while the FY2025 annual figure was $416682.0, down 50.25% from the prior year.
• Accounts Payables came in at $889733.0 for Q2 2026 at Mangoceuticals, up from $529800.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.2 million in Q1 2025 to a low of $30796.0 in Q1 2023.
• Average Accounts Payables over 5 years is $534231.3, with a median of $529800.0 recorded in 2026.
• Year-over-year, Accounts Payables surged 3198.95% in 2024 and slumped 55.03% in 2026.
• Over 5 years, Accounts Payables stood at $33675.0 in 2022, then soared by 318.01% to $140765.0 in 2023, then jumped by 494.96% to $837501.0 in 2024, then slumped by 50.25% to $416682.0 in 2025, then jumped by 113.53% to $889733.0 in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $889733.0 in Q2 2026, $529800.0 in Q1 2026, and $416682.0 in Q4 2025.